Indication DUPIXENT is indicated as an add-on maintenance treatment in adult patients with inadequately controlled chronic rhinosinusitis with nasal polyposis (CRSwNP).

Choose DUPIXENT—a novel add-on biologic option for adults with uncontrolled CRSwNP

Patient profile is representative and
is not an actual DUPIXENT patient.

MEDICAL HISTORY

  • Confirmed diagnosis of CRSwNP by visual examination
  • CRSwNP duration: 8 years
  • 2 SCS bursts in the previous year
  • INCS
  • History of asthma

CLINICAL CHARACTERISTICS

  • NC score (0-3): 2.2
  • NPS (0-8): 6.1
  • SNOT-22 score (0-110): 46
  • 48 Years old

Patient profile is representative and
is not an actual DUPIXENT patient.

MEDICAL HISTORY

  • Confirmed diagnosis of comorbidities:
    • CRSwNP by anterior rhinoscopy and endoscopy 14 years ago
    • Asthma 10 years ago
    • NSAID-ERD by aspirin challenge
  • 2 OCS bursts in the past year
  • 3 previous sino-nasal surgeries
  • Reports loss of smell
  • INCS and medium-dose ICS/LABA

CLINICAL CHARACTERISTICS

  • Bilateral endoscopic NPS (0-8): 6
  • LMK-CT score (0-24): 18
  • SNOT-22 score (0-110): 55
  • FEV1 60% predicted (L): 2.5
  • 45 Years old

Patient profile is representative and
is not an actual DUPIXENT patient.

MEDICAL HISTORY

  • Confirmed diagnosis of CRSwNP by rhinoscopy (endoscopy)
  • CRSwNP duration: 12 years
  • 1 previous sino-nasal surgery
  • 3 SCS bursts in the previous year
  • Nasal irrigation and INCS for nasal symptoms
  • Reports loss of smell and congestion

CLINICAL CHARACTERISTICS

  • NC score (0-3): 2.8
  • NPS (0-8): 5.5
  • SNOT-22 score (0-110): 55
  • 51 Years old

CHOOSE DUPIXENT FOR PATIENTS with uncontrolled CRSwNP

CRSwNP, chronic rhinosinusitis with nasal polyposis; FEV1, forced expiratory volume in 1 second; ICS, inhaled corticosteroids; INCS, intranasal corticosteroids; LABA, long-acting beta agonist; LMK-CT, Lund-Mackay computed tomography; NC, nasal congestion/obstruction; NPS, nasal polyps score; NSAID-ERD, nonsteroidal anti-inflammatory drug–exacerbated respiratory disease; OCS, oral corticosteroid; SCS, systemic corticosteroid; SNOT-22, 22-item Sino-Nasal Outcome Test.

Identify CRSwNP
patients appropriate
for DUPIXENT

View Patients